Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
Clinical trial NCT02229383 · COMPLETED
Trial details
- NCT number
- NCT02229383
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-06
- Primary completion
- 2016-08-29
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.